TPG Discloses 7.8% Stake in Odyssey Therapeutics, Including $25M Private Placement Post-IPO
ODTX is trading near its 52-week low of $16.405 (6.0% above the low).
Summary
TPG and its affiliates disclosed a 7.8% beneficial ownership stake in Odyssey Therapeutics, including a $25 million private placement at the IPO price, signaling strong institutional confidence post-IPO.
Key Events · Ownership and Investor Activity · ODTX
-
Significant Stake Disclosure
TPG GP A, LLC and its affiliates, including James G. Coulter and Jon Winkelried, disclosed a 7.8% beneficial ownership stake in Odyssey Therapeutics, totaling 3,690,146 shares.
-
Private Placement Investment
TPG Orazio II, an affiliate, completed a $25 million private placement on May 11, 2026, purchasing 1,388,889 shares at the IPO price of $18.00 per share.
-
Substantial Institutional Backing
The total beneficial ownership represents a substantial investment, valued at approximately $66.4 million based on the IPO price, indicating strong institutional confidence in the newly public company.
-
Post-IPO Timing
This filing follows the company's recent initial public offering on May 8, 2026, and provides details on a previously announced private placement, solidifying TPG's position as a major investor.
Analysis · ODTX · Life Sciences
This Schedule 13D filing reveals that TPG, a prominent investment firm, has taken a significant 7.8% stake in Odyssey Therapeutics. A key part of this stake includes a $25 million private placement completed at the IPO price, demonstrating TPG's confidence in the company's valuation and future prospects shortly after its public debut. This substantial investment from a major institutional player provides a strong vote of confidence for the newly public company.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 37.4% of the 3413 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ODTX was trading at $17.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $823.1M. The 52-week trading range was $16.41 to $18.06. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.